Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-03-05

FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application for butorphanol tartrate from Apotex Corp., updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butorphanol Tartrate (Butorphanol tartrate)

Snippet

SUPPL AP for BUTORPHANOL TARTRATE (BUTORPHANOL TARTRATE)